Corrigendum to "Combining anti-PD-1 antibodies with Mn-drug coordinated multifunctional nanoparticles for enhanced cancer therapy" [Biomaterials 275 (2021) 120897].

Biomaterials

Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Institute of Molecular Medicine, State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China; Shanghai Key Laboratory of Gynecologic Oncology, Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China. Electronic address:

Published: June 2022

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biomaterials.2022.121563DOI Listing

Publication Analysis

Top Keywords

corrigendum "combining
4
"combining anti-pd-1
4
anti-pd-1 antibodies
4
antibodies mn-drug
4
mn-drug coordinated
4
coordinated multifunctional
4
multifunctional nanoparticles
4
nanoparticles enhanced
4
enhanced cancer
4
cancer therapy"
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!